GS
Gene Salkind

Gene Salkind insider trades: Upexi (UPXI) stock purchases

Upexi Last trade Nov 20, 2025 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$674K
Bought, last 12 months
3 buys
9
Open-market trades
since 2019
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gene reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 20, 2025UPXI↑ Buy$127K
Nov 17, 2025UPXI↑ Buy$281K
Nov 17, 2025UPXI↑ Buy$265K
Jul 11, 2025UPXI↑ Buy$100K
Apr 17, 2025UPXI↑ Buy$550K
Jan 5, 2024COEP↑ Buy$8K
Aug 29, 2023COEP↑ Buy$30K
Mar 30, 2022GRVI↑ Buy$500K
Sep 13, 2019MOBQ↑ Buy$3.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UPXI insiders

Open-market trades in the last 12 months

About Gene Salkind's insider trades

Gene Salkind is an insider at Upexi (UPXI). Since Sep 13, 2019, Gene has reported 9 open-market purchases worth $5.1M and no sales on SEC Form 4. In the last 12 months: 3 buys ($674K).

Their filings also include grants and awards (28 filings), option exercises (5 filings), conversions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UPXI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.